Literature DB >> 11821126

mRNA secondary structure can greatly affect production of recombinant phospholipase A(2) toxins in bacteria.

G Ivanovski1, F Gubensek, J Pungercar.   

Abstract

The neurotoxic activity of ammodytoxin A (AtxA), a phospholipase A(2) from Vipera ammodytes ammodytes venom, has been investigated by protein engineering. With the aim of obtaining AtxA as a non-fused protein in the bacterial cytoplasm and avoiding problems with incomplete cleavage in vivo of the initial Met preceding the first residue (Ser1), a double mutant (S1A/E4Q) was prepared and expressed in Escherichia coli. Immunoblotting of the bacterial lysate showed that the mutant was synthesized at a low level not exceeding 0.5% of total cell protein. Analysis of the potential secondary structure of the mutant mRNA in the translation initiation region suggested that the Ala1 (GCC) and Leu2 (CUG) codons used are likely to be involved in a hairpin structure with the Thr13 (ACG) and Gly14 (GGG) codons, hindering effective translation at the ribosome. To weaken this structure (by DeltaG of about 20 kJ/mol) the same double mutant was prepared using another mutagenic oligonucleotide with silent mutations in the Ala1 (GCU) and Leu2 (UUG) codons. The mutant was successfully produced at a level of approximately 15% of total protein, with the initial Met completely removed in the bacterial cell. Such an approach could be important in solving similar problems in bacterial production of other toxic proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821126     DOI: 10.1016/s0041-0101(01)00250-1

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  2 in total

1.  RNA stem-loop enhanced expression of previously non-expressible genes.

Authors:  Michael Paulus; Martin Haslbeck; Manfred Watzele
Journal:  Nucleic Acids Res       Date:  2004-05-26       Impact factor: 16.971

2.  Reappraisal of Vipera aspis venom neurotoxicity.

Authors:  Elisabeth Ferquel; Luc de Haro; Virginie Jan; Isabelle Guillemin; Sabine Jourdain; Alexandre Teynié; Jacques d'Alayer; Valérie Choumet
Journal:  PLoS One       Date:  2007-11-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.